Epstein-Barr virus-associated pneumonia in patients with post-transplant lymphoproliferative disease after hematopoietic stem cell transplantation

Transplant Infectious Disease

Volumn 12, Issue 4, 2010, Pages 284-291

  Liu, Q F ^a   Fan, Z P ^a   Luo, X D ^a   Sun, J ^a   Zhang, Y ^a   Ding, Y Q ^a  

^a SOUTHERN MEDICAL UNIVERSITY   (China)

Author keywords

EBV; Epstein Barr virus; hematopoietic stem cell transplantation; pneumonia; post transplant lymphoproliferative disease; PTLD

Indexed keywords

ACICLOVIR; AMPHOTERICIN B LIPID COMPLEX; BASILIXIMAB; CD19 ANTIGEN; CD20 ANTIGEN; CD45RO ANTIGEN; CYCLOSPORIN A; FLUCONAZOLE; GANCICLOVIR; ITRACONAZOLE; METHOTREXATE; METHYLPREDNISOLONE; MYCOPHENOLIC ACID; NORFLOXACIN; SULFAMETHOXAZOLE; THYMOCYTE ANTIBODY; VIRUS DNA; VORICONAZOLE;

ADOLESCENT; ADULT; ARTICLE; B CELL LYMPHOMA; CD3+ T LYMPHOCYTE; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; DYSPNEA; EPSTEIN BARR VIRUS; EPSTEIN BARR VIRUS INFECTION; FEMALE; GRAFT VERSUS HOST REACTION; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; HUMAN TISSUE; HYPERPYREXIA; LUNG BIOPSY; LUNG LAVAGE; LYMPHOID HYPERPLASIA; LYMPHOPROLIFERATIVE DISEASE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; T CELL LYMPHOMA; VIRUS PNEUMONIA;

ADOLESCENT; ADULT; EPSTEIN-BARR VIRUS INFECTIONS; FEMALE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HERPESVIRUS 4, HUMAN; HUMANS; LUNG; LYMPHOPROLIFERATIVE DISORDERS; MALE; PNEUMONIA, VIRAL; TRANSPLANTATION, AUTOLOGOUS; TRANSPLANTATION, HOMOLOGOUS;

EID: 77955973354     PISSN: 13982273     EISSN: 13993062     Source Type: Journal    
DOI: 10.1111/j.1399-3062.2010.00502.x     Document Type: Article

References (39)

1. Curtis RE, Travis LB, Rowlings PA, et al. Risk of lymphoproliferative disorders after bone marrow transplantation: a multi-institutional study. Blood 1999 94 (7) : 2208 2216.
2. Bitan M. Epstein-Barr virus infection after stem cell transplantation: new concepts are needed both for the donor and the recipient. Clin Infect Dis 2006 43 (7) : 896 897.
3. Teira P, Agbalika F, Bergeron A, et al. Primary Epstein-Barr virus infection with pneumonia transmitted by allogeneic bone marrow after transplantation. Clin Infect Dis 2006 43 (7) : 892 895.
4. Marzouk K, Corate L, Saleh S, Sharma OP. Epstein-Barr-virus-induced interstitial lung disease. Curr Opin Pulm Med 2005 11 (5) : 456 460.
5. Loren AW, Tsai DE. Post-transplant lymphoproliferative disorder. Clin Chest Med 2005 26 (4) : 631 645, vii.
6. Siegel MJ, Lee EY, Sweet SC, et al. CT of posttransplantation lymphoproliferative disorder in pediatric recipients of lung allograft. AJR Am J Roentgenol 2003 181 (4) : 1125 1131.
7. Kunitomi A, Arima N, Ishikawa T. Epstein-Barr virus-associated post-transplant lymphoproliferative disorders presented as interstitial pneumonia; successful recovery with rituximab. Haematologica 2007 92 (4) : e49 e52.
8. Kim EA, Lee KS, Primack SL, et al. Viral pneumonias in adults: radiologic and pathologic findings. Radiographics 2002 Spec. no. 22: S137-149.
9. Liu QF, Sun J, Xu D, et al. Effects of allogeneic hematopoietic stem cell transplantation with very-high-dose conditioning regimen for refractory leukemia. Di Yi Jun Yi Da Xue Xue Bao 2004 24 (101) : 1117 1119.
10. Liu HX, Ding YQ, Sun YO, et al. Detection of Epstein-Barr virus in human colorectal cancer by in situ hybridization. Di Yi Jun Yi Da Xue Xue Bao 2004 22 (10) : 915 917.
11. Liu QF, Song LL, Zhang Y, et al. The clinical significance of interphase fluorescence in situ hybridization monitoring chimeric status after sex-mismatched allogeneic hematopoietic stem cell transplantation for leukemia. Zhonghua Yi Xue Yi Chuan Xue Za Zhi 2005 22 (2) : 212 215.
12. Taylor AL, Marcus R, Bradley JA. Post-transplant lymphoproliferative disorders (PTLD) after solid organ transplantation. Crit Rev Oncol Hematol 2005 56 (1) : 155 167.
13. Harris NL, Ferry JA, Swerdlow SH. Posttransplant lymphoproliferative disorders: summary of Society for Hematopathology workshop. Semin Diagn Pathol 1997 14 (1) : 8 14.
14. Penn I, Hammon W, Brettschneider L, Starzl TE. Malignant lymphomas in transplantation patients. Transplant Proc 1969 1 (1) : 106 112.
15. McKhann CF. Primary malignancy in patients undergoing immunosuppression for renal transplantation. Transplantation 1969 8 (2) : 209 212.
16. Dolcetti R. B lymphocytes and Epstein-Barr virus: the lesson of post-transplant lymphoproliferative disorders. Autoimmun Rev 2007 7 (2) : 96 101.
17. Lowe T, Bhatia S, Somlo G. Second malignancies after allogeneic Hematopoietic cell transplantation. Biol Blood Marrow Transplant 2007 13 (10) : 1121 1134.
18. Orazi A, Hromas RA, Neiman RS, et al. Posttransplantation lymphoproliferative disorders in bone marrow transplant recipients are aggressive diseases with a high incidence of adverse histologic and immunobiologic features. Am J Clin Pathol 1997 107 (4) : 419 429.
19. Liebowitz D. Epstein-Barr virus and a cellular signaling pathway in lymphomas from immunosuppressed patients. N Engl J Med 1998 338 (20) : 1413 1421.
20. Cockfield SM. Identifying the patient at risk for post-transplant lymphoproliferative disorder. Transpl Infect Dis 2001 3 (2) : 70 78.
21. Shapiro RS, McClain K, Frizzera G, et al. Epstein-Barr virus associated B cell lymphoproliferative disorders following bone marrow transplantation. Blood 1988 71 (5) : 1234 1243.
22. Yufu Y, Kimura M, Kawano R, et al. Epstein-Barr virus-associated T cell lymphoproliferative disorder following autologous blood stem cell transplantation for relapsed Hodgkin's disease. Bone Marrow Transplant 2000 26 (12) : 1339 1341.
23. Nash RA, Dansey R, Storek J, et al. Epstein-Barr virus-associated posttransplantation lymphoproliferative disorder after high-dose immunosuppressive therapy and autologous CD34-selected hematopoietic stem cell transplantation for severe autoimmune diseases. Biol Blood Marrow Transplant 2003 9 (9) : 583 591.
24. Awaya N, Adachi A, Mori T, et al. Fulminant Epstein-Barr virus (EBV)-associated T-cell lymphoproliferative disorder with hemophagocytosis following autologous peripheral blood stem cell transplantation for relapsed angioimmunoblastic T-cell lymphoma. Leuk Res 2006 30 (8) : 1059 1062.
25. Craig FE, Johnson LR, Harvey SA, et al. Gene expression profiling of Epstein-Barr virus-positive and -negative monomorphic B-cell posttransplant lymphoproliferative disorders. Diagn Mol Pathol 2007 16 (3) : 158 168.
26. Lundell R, Elenitoba-Johnson KS, Lim MS. T-cell posttransplant lymphoproliferative disorder occurring in a pediatric solid-organ transplant patient. Am J Surg Pathol 2004 28 (7) : 967 973.
27. Nelson BP, Nalesnik MA, Bahler DW, Locker J, Fung JJ, Swerdlow SH. Epstein-Barr virus-negative post-transplant lymphoproliferative disorders: a distinct entity? Am J Surg Pathol 2000 24 (3) : 375 385.
28. Loren AW, Porter DL, Stadtmauer EA, Tsai DE. Post-transplant lymphoproliferative disorder: a review. Bone Marrow Transplant 2003 31 (3) : 145 155.
29. Copp DH, Godwin JD, Kirby KA, Kimaye AP. Clinical and radiologic factors associated with pulmonary nodule etiology in organ transplant recipients. Am J Transplant 2006 6 (11) : 2759 2764.
30. Britton S, Andersson-Anvret M, Gergely P, et al. Epstein-Barr-virus immunity and tissue distribution in a fatal case of infectious mononucleosis. N Engl J Med 1978 298 (2) : 89 92.
31. Xu LP, Huang XJ, Liu DH, Chen YH, Shi HX, Chen DB. A clinical study of lymphoproliferative disorders following allogeneic hematopoietic stem cell transplantation. Zhonghua Yi Xue Za Zhi 2007 46 (12) : 996 999.
32. Pfleger A, Eber E, Popper H, Zach MS. Chronic interstitial lung disease due to Epstein-Barr virus infection in two infants. Eur Respir J 2000 15 (4) : 803 806.
33. Stopyra GA, Multhaupt HA, Alexa L, et al. Epstein-Barr virus-associated adult respiratory distress syndrome in a patient with AIDS: a case report and review. Mod Pathol 1999 12 (10) : 984 989.
34. Shimakage M, Kimura M, Yanoma S, et al. Expression of latent and replicative-infection genes of Epstein-Barr virus in macrophage. Arch Virol 1999 144 (1) : 157 166.
35. Kasahara Y, Yachie A, Takei K, et al. Differential cellular targets of Epstein-Barr virus (EBV) infection between acute EBV-associated hemophagocytic lymphohistiocytosis and chronic active EBV infection. Blood 2001 98 (6) : 1882 1888.
36. Hashimoto Y, Nawata Y, Kurasawa K, et al. Investigation of EB virus and cytomegalovirus in rapidly progressive interstitial pneumonitis in polymyositis/dermatomyositis by in situ hybridization and polymerase chain reaction. Clin Immunol Immunopathol 1995 77 (3) : 298 306.
37. Stewart JP, Egan JJ, Ross AJ, et al. The detection of Epstein-Barr virus DNA in lung tissue from patients with idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 1999 159 (4 Pt 1) : 1336 1341.
38. Liebowitz D, Wang D, Kieff E. Orientation and patching the latent infection membrane protein encoded by Epstein-Barr virus. J Virol 1986 58 (1) : 233 237.
39. Dawson CW, Rickinson AB, Young LS. Epstein-Barr virus latent membrane protein inhibits human epithelial cell differentiation. Nature 1990 344 : 777 780.